Searching News Database: Gilead Sciences
HSMN NewsFeed - 15 Feb 2024
Compugen Announces Appointment of Michelle Mahler M.D. as Chief Medical Officer
Compugen Announces Appointment of Michelle Mahler M.D. as Chief Medical Officer
HSMN NewsFeed - 1 Nov 2023
cTRL Therapeutics Appoints Derrell D. Porter, M.D., as Chief Executive Officer
cTRL Therapeutics Appoints Derrell D. Porter, M.D., as Chief Executive Officer
HSMN NewsFeed - 6 Sep 2023
OncoResponse Announces Appointment of Carol Gallagher to Board of Directors
OncoResponse Announces Appointment of Carol Gallagher to Board of Directors
HSMN NewsFeed - 3 Aug 2023
Kyverna Therapeutics Extends Series B Financing Round to $145 Million and Brings in New Investors
Kyverna Therapeutics Extends Series B Financing Round to $145 Million and Brings in New Investors
HSMN NewsFeed - 25 Oct 2022
Actinium Bolsters its Senior Leadership Team Ahead of Upcoming Clinical Data for Iomab-B
Actinium Bolsters its Senior Leadership Team Ahead of Upcoming Clinical Data for Iomab-B
HSMN NewsFeed - 21 Jun 2022
Chemomab Therapeutics Appoints Jill M. Quigley, JD, to Its Board of Directors
Chemomab Therapeutics Appoints Jill M. Quigley, JD, to Its Board of Directors
HSMN NewsFeed - 26 Jan 2022
Kyverna Therapeutics Closes $85 Million Series B Financing led by Northpond Ventures
Kyverna Therapeutics Closes $85 Million Series B Financing led by Northpond Ventures
HSMN NewsFeed - 17 May 2021
INOVIO Announces Appointment Of Roger Dansey, M.D., to its Board of Directors
INOVIO Announces Appointment Of Roger Dansey, M.D., to its Board of Directors
HSMN NewsFeed - 4 May 2020
SutroVax Appoints Andrew Guggenhime as Chief Financial Officer and Chief Business Officer
SutroVax Appoints Andrew Guggenhime as Chief Financial Officer and Chief Business Officer
HSMN NewsFeed - 6 Dec 2019
Apexigen Expands Leadership Team with Two Key Appointments in CMC and Clinical Development
Apexigen Expands Leadership Team with Two Key Appointments in CMC and Clinical Development
HSMN NewsFeed - 8 Jul 2019
Soligenix Announces Appointment of Diane L. Parks to its Board of Directors
Soligenix Announces Appointment of Diane L. Parks to its Board of Directors
HSMN NewsFeed - 1 Oct 2018
Arix Bioscience plc Co-leads $58 Million Series A Investment Round for VelosBio
Arix Bioscience plc Co-leads $58 Million Series A Investment Round for VelosBio
HSMN NewsFeed - 12 Sep 2018
Sutro Taps Worsley as Chief Business Officer; Names Fitzpatrick as People and Communications Chief
Sutro Taps Worsley as Chief Business Officer; Names Fitzpatrick as People and Communications Chief
HSMN NewsFeed - 11 Sep 2018
Andrew Cheng, MD, PhD Joins Akero Therapeutics as President and Chief Executive Officer
Andrew Cheng, MD, PhD Joins Akero Therapeutics as President and Chief Executive Officer
HSMN NewsFeed - 31 Jul 2018
Natera Appoints Roy Baynes to Board of Directors, Adding Deep Oncology Experience
Natera Appoints Roy Baynes to Board of Directors, Adding Deep Oncology Experience
HSMN NewsFeed - 4 Apr 2018
Mallinckrodt Names Paul R. Carter, Anne C. Whitaker to its Board of Directors
Mallinckrodt Names Paul R. Carter, Anne C. Whitaker to its Board of Directors
HSMN NewsFeed - 3 Oct 2017
Oncorus(R), Inc., Names Christophe Quéva, Ph.D., as Chief Scientific Officer
Oncorus(R), Inc., Names Christophe Quéva, Ph.D., as Chief Scientific Officer
HSMN NewsFeed - 28 Nov 2016
Addex Appoints Biopharmaceutical Industry Veteran, Roger G. Mills, M.D., as Chief Medical Officer
Addex Appoints Biopharmaceutical Industry Veteran, Roger G. Mills, M.D., as Chief Medical Officer
HSMN NewsFeed - 13 Jan 2016
Galapagos and Gilead Cleared by U.S. Federal Trade Commission to Close Global Partnership on Filgotinib
Galapagos and Gilead Cleared by U.S. Federal Trade Commission to Close Global Partnership on Filgotinib
HSMN NewsFeed - 16 Jul 2015
Exelixis Appoints Chris Senner as Executive Vice President and Chief Financial Officer
Exelixis Appoints Chris Senner as Executive Vice President and Chief Financial Officer
HSMN NewsFeed - 10 Jun 2015
GlobeImmune Announces Evaluation of Strategic Alternatives and Corporate Restructuring
GlobeImmune Announces Evaluation of Strategic Alternatives and Corporate Restructuring
HSMN NewsFeed - 23 Feb 2015
Mylan Signs Exclusive Agreement with Gilead Sciences to Distribute Sovaldi(R) and Harvoni(R) in India
Mylan Signs Exclusive Agreement with Gilead Sciences to Distribute Sovaldi(R) and Harvoni(R) in India
HSMN NewsFeed - 1 Jul 2014
Paratek Appoints Michael Bigham as Chairman and CEO and Promotes Evan Loh to President and CMO
Paratek Appoints Michael Bigham as Chairman and CEO and Promotes Evan Loh to President and CMO
HSMN NewsFeed - 14 May 2014
Acorda Therapeutics Appoints Andrew Hindman as Chief Business Development Officer
Acorda Therapeutics Appoints Andrew Hindman as Chief Business Development Officer
HSMN NewsFeed - 9 Apr 2014
Chimerix Announces Appointment of M. Michelle Berrey, M.D., M.P.H. as Chief Executive Officer
Chimerix Announces Appointment of M. Michelle Berrey, M.D., M.P.H. as Chief Executive Officer
HSMN NewsFeed - 27 Mar 2014
Oculus Innovative Sciences Announces Appointment of Sharon Barbari to Its Board of Directors
Oculus Innovative Sciences Announces Appointment of Sharon Barbari to Its Board of Directors
HSMN NewsFeed - 14 Mar 2014
Idenix Pharmaceuticals Files Patent Infringement Lawsuits Against Gilead Sciences in Europe
Idenix Pharmaceuticals Files Patent Infringement Lawsuits Against Gilead Sciences in Europe
HSMN NewsFeed - 31 Jan 2014
Mylan Named as Gilead's Exclusive Branded Medicines Business Partner for India
Mylan Named as Gilead's Exclusive Branded Medicines Business Partner for India
HSMN NewsFeed - 6 Jan 2014
Gilead Sciences’ Kevin Young CBE, Executive Vice President, Commercial Operations, to Retire
Gilead Sciences’ Kevin Young CBE, Executive Vice President, Commercial Operations, to Retire
HSMN NewsFeed - 6 Jan 2014
Kala Pharmaceuticals Appoints Howard B. Rosen as Chairman of the Board of Directors
Kala Pharmaceuticals Appoints Howard B. Rosen as Chairman of the Board of Directors
HSMN NewsFeed - 2 Dec 2013
Idenix Pharmaceuticals Files Patent Infringement and Interference Lawsuits Against Gilead Sciences
Idenix Pharmaceuticals Files Patent Infringement and Interference Lawsuits Against Gilead Sciences
HSMN NewsFeed - 12 Aug 2013
Tekmira Strengthens Development Team With Appointment of Dr. Mark Kowalski as Chief Medical Officer
Tekmira Strengthens Development Team With Appointment of Dr. Mark Kowalski as Chief Medical Officer
HSMN NewsFeed - 5 Jun 2013
Peter J. Carbonaro Joins Atossa Genetics as Senior Vice President of Operations
Peter J. Carbonaro Joins Atossa Genetics as Senior Vice President of Operations
HSMN NewsFeed - 15 May 2013
Achillion Appoints Dr. David Apelian as Chief Medical Officer and Expands Clinical Operations Team
Achillion Appoints Dr. David Apelian as Chief Medical Officer and Expands Clinical Operations Team
HSMN NewsFeed - 18 Oct 2012
Omeros Adds Vice Presidents of Regulatory and Clinical to Management Team
Omeros Adds Vice Presidents of Regulatory and Clinical to Management Team
HSMN NewsFeed - 18 Oct 2011
Tranzyme Pharma Names Former Gilead Executive Franck Rousseau, M.D. Chief Medical Officer
Tranzyme Pharma Names Former Gilead Executive Franck Rousseau, M.D. Chief Medical Officer
HSMN NewsFeed - 25 May 2011
BioCryst Pharmaceuticals Announces Appointment of Thomas Staab as Its Next Chief Financial Officer
BioCryst Pharmaceuticals Announces Appointment of Thomas Staab as Its Next Chief Financial Officer
HSMN NewsFeed - 4 Apr 2011
Tobira Therapeutics Appoints Andrew Hindman President and Chief Executive Officer
Tobira Therapeutics Appoints Andrew Hindman President and Chief Executive Officer
HSMN NewsFeed - 21 Dec 2010
Ramius and Royalty Pharma Extend Tender Offer Until January 5, 2011 Pursuant to Definitive Merger Agreement
Ramius and Royalty Pharma Extend Tender Offer Until January 5, 2011 Pursuant to Definitive Merger Agreement
HSMN NewsFeed - 22 Jul 2010
Alexza Pharmaceuticals Appoints Joseph L. Turner to Its Board of Directors
Alexza Pharmaceuticals Appoints Joseph L. Turner to Its Board of Directors
HSMN NewsFeed - 8 Jan 2010
Industry Veteran Ron Branning Joins Genzyme to Lead Global Product Quality
Industry Veteran Ron Branning Joins Genzyme to Lead Global Product Quality
HSMN NewsFeed - 17 Dec 2009
Medivation Announces Organizational Changes to Support Anticipated Growth and Future Commercialization
Medivation Announces Organizational Changes to Support Anticipated Growth and Future Commercialization
HSMN NewsFeed - 17 Sep 2009
Juvaris BioTherapeutics Announces First Close on $25 million Series B Financing
Juvaris BioTherapeutics Announces First Close on $25 million Series B Financing
HSMN NewsFeed - 7 Jul 2009
OncoMed Pharmaceuticals Appoints Sunil Patel Senior Vice President, Corporate Development
OncoMed Pharmaceuticals Appoints Sunil Patel Senior Vice President, Corporate Development
HSMN NewsFeed - 30 Mar 2009
Mylan's Matrix Receives First Tentative FDA Approval Under PEPFAR for Generic Truvada(R)
Mylan's Matrix Receives First Tentative FDA Approval Under PEPFAR for Generic Truvada(R)
HSMN NewsFeed - 11 Feb 2009
AspenBio Appoints Robert Caspari, M.D. as Chief Operating Officer and Chief Medical Officer
AspenBio Appoints Robert Caspari, M.D. as Chief Operating Officer and Chief Medical Officer
HSMN NewsFeed - 28 Jan 2009
BAROFOLD, INC. APPOINTS J. WILLIAM FREYTAG, Ph.D. AS PRESIDENT AND CHIEF EXECUTIVE OFFICER
BAROFOLD, INC. APPOINTS J. WILLIAM FREYTAG, Ph.D. AS PRESIDENT AND CHIEF EXECUTIVE OFFICER
HSMN NewsFeed - 11 Sep 2008
Seigo Izumo, MD Joins Gilead as Senior Vice President, Cardiovascular Therapeutics
Seigo Izumo, MD Joins Gilead as Senior Vice President, Cardiovascular Therapeutics
HSMN NewsFeed - 11 Aug 2008
U.S. Food and Drug Administration Approves Viread(R) for Chronic Hepatitis B in Adults
U.S. Food and Drug Administration Approves Viread(R) for Chronic Hepatitis B in Adults
HSMN NewsFeed - 29 May 2008
Gilead and Navitas Announce Agreement for Cicletanine for the Treatment of Pulmonary Arterial Hypertension
Gilead and Navitas Announce Agreement for Cicletanine for the Treatment of Pulmonary Arterial Hypertension
HSMN NewsFeed - 6 Mar 2008
Gilead Appoints Dr. John J. Toole as Senior Vice President, Corporate Development
Gilead Appoints Dr. John J. Toole as Senior Vice President, Corporate Development
HSMN NewsFeed - 23 Jan 2008
Carol L. Brosgart, M.D., Appointed to the Board of Directors of Juvaris BioTherapeutics, Inc.
Carol L. Brosgart, M.D., Appointed to the Board of Directors of Juvaris BioTherapeutics, Inc.
HSMN NewsFeed - 17 Jan 2008
Oculus Innovative Sciences, Inc. Appoints Gregg Alton to its Board of Directors
Oculus Innovative Sciences, Inc. Appoints Gregg Alton to its Board of Directors
HSMN NewsFeed - 4 Dec 2007
Mylan Announces Tentative FDA Approval Under PEPFAR for Tenofovir Disoproxil Fumarate Tablets
Mylan Announces Tentative FDA Approval Under PEPFAR for Tenofovir Disoproxil Fumarate Tablets
HSMN NewsFeed - 18 Oct 2007
Caroline Dorsa to Join Gilead as Senior Vice President and Chief Financial Officer
Caroline Dorsa to Join Gilead as Senior Vice President and Chief Financial Officer
HSMN NewsFeed - 10 Oct 2007
Accera, Inc. Names William T. Poncy Vice President of Commercial Development
Accera, Inc. Names William T. Poncy Vice President of Commercial Development
HSMN NewsFeed - 1 Aug 2007
Tobira Therapeutics Inc. Completes $31 Million Series A Financing and Names Management Team
Tobira Therapeutics Inc. Completes $31 Million Series A Financing and Names Management Team
HSMN NewsFeed - 11 Jul 2007
J. William Freytag, PH.D. appointed Chairman and Chief Executive Officer of Aspreva Pharmaceuticals
J. William Freytag, PH.D. appointed Chairman and Chief Executive Officer of Aspreva Pharmaceuticals
HSMN NewsFeed - 2 Jul 2007
Tamiflu(R) 30 mg and 45 mg Capsules Approved by U.S. Food and Drug Administration
Tamiflu(R) 30 mg and 45 mg Capsules Approved by U.S. Food and Drug Administration
HSMN NewsFeed - 15 May 2007
Achillion Appoints OSI Executive Robert Van Nostrand to Board of Directors
Achillion Appoints OSI Executive Robert Van Nostrand to Board of Directors
HSMN NewsFeed - 25 Apr 2007
Acceleron Pharma Appoints James Desiderio, Ph.D. as Vice President, Program Management
Acceleron Pharma Appoints James Desiderio, Ph.D. as Vice President, Program Management
HSMN NewsFeed - 26 Oct 2006
Gilead Sciences Announces Early Termination of Hart-Scott-Rodino Waiting Period
Gilead Sciences Announces Early Termination of Hart-Scott-Rodino Waiting Period
HSMN NewsFeed - 26 Jun 2006
BioAlliance Pharma Strengthens Operational Management Ahead of Loramyc(R) Launch
BioAlliance Pharma Strengthens Operational Management Ahead of Loramyc(R) Launch
HSMN NewsFeed - 11 May 2006
Diatos Announces Acquisition of Specialty Cancer Product DaunoXome(R) from Gilead Sciences
Diatos Announces Acquisition of Specialty Cancer Product DaunoXome(R) from Gilead Sciences
HSMN NewsFeed - 8 May 2006
Connetics Names Sunil Patel Vice President, Corporate Development and Strategy
Connetics Names Sunil Patel Vice President, Corporate Development and Strategy
Additional items found! 75
Members Archive contains
75 additional stories matching:
Gilead Sciences
(Password required)
Gilead Sciences
(Password required)